Amgen Inc. Notes Payable, Noncurrent
Amgen Inc. (AMGN) had Notes Payable, Noncurrent of $29.52 billion as of 2014-03-31, per its 10-Q filed 2014-04-30.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Excluding Current Maturities › Notes Payable, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2014-04-30
- 2014-03-31: Notes Payable, Noncurrent $29.52B.
- 2013-12-31: Notes Payable, Noncurrent $29.62B.
- 2013-09-30: Notes Payable, Noncurrent $27.18B.
- 2013-06-30: Notes Payable, Noncurrent $23.91B.
| Period end | Notes Payable, Noncurrent | Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2014-03-31 | $29.52B 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $29.62B 10-Q · filed 2014-04-30 | |
| 2013-09-30 | $27.18B 10-Q · filed 2013-10-29 | |
| 2013-06-30 | $23.91B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $23.89B 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $24.03B 10-K · filed 2014-02-24 | |
| 2012-09-30 | $24.02B 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $21.96B 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $19.03B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $21.34B 10-K · filed 2013-02-27 | |
| 2011-09-30 | $13.88B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $11.57B 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $8.58B 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $10.87B 10-K · filed 2012-02-29 | $8.58B 10-K · filed 2011-02-25 |
| 2010-09-30 | $8.58B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $7.09B 10-Q · filed 2010-08-09 | |
| 2010-03-31 | $7.08B 10-Q · filed 2010-05-07 | |
| 2009-12-31 | $6.09B 10-K · filed 2011-02-25 | |
| 2009-09-30 | $6.09B 10-Q · filed 2009-11-06 | |
| 2009-06-30 | $6.09B 10-Q · filed 2009-08-10 | |
| 2008-12-31 | $4.09B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |